Study directory

Mental health studies with practical context.

Compare studies and check their requirements with the research team.

Back to overview
More filters: keywords, city, remote
214studies shown
Showing 85-96 of 214
Drug study icon
CompletedNCT01121042

Double Blind, Investigation of Ondansetron in Schizophrenia

This study is completed in Australia. It is testing Double Blind, Placebo-Controlled, Randomised Investigation of Ondansetron for schizophrenia.

In Australia
SchizophreniaDrugA study involving a medication or substance.From 18 Years to 65 Years
Countries
Australia
Sponsor
Bayside Health
Condition
Schizophrenia
Other study type icon
CompletedNCT04866030

Drug Use Study With Intuniv® in Australia

This summary needs review. Please check the official study record and contact the research team for details.

In Australia
ADHDObservationalA study where researchers collect information without assigning a treatment.From 6 Years to 17 Years
Countries
Australia
Sponsor
Shire
Condition
ADHD
Behavioral study icon
CompletedNCT04378101

Eating disorders Genetics Initiative

This summary needs review. Please check the official study record and contact the research team for details.

In Australia
Eating disordersBehavioralFrom 15 Years to 99 Years
Countries
United States, Australia, New Zealand
Sponsor
University of North Carolina, Chapel Hill
Condition
Eating disorders
Drug study icon
TerminatedNCT06483789

HB-1 for Anxiety

This study was terminated in Australia. It is testing HB-1 for Anxiety.

In Australia
AnxietyDrugFrom 18 Years to 65 Years
Countries
Australia
Sponsor
HB BioTech, LLC
Condition
Anxiety
Drug study icon
TerminatedNCT00622245

Lu AA34893 for depression in bipolarity

This study was terminated in Australia, in France, in Canada, .... It is testing Lu AA34893 for depression in bipolarity.

In Australia
Bipolarity, DepressionDrugFrom 18 Years to 65 Years
Countries
Australia, France, Canada, ...
Sponsor
H. Lundbeck A/S
Condition
Bipolarity, Depression
Device study icon
Active Not RecruitingNCT03788811

ERG Components in Schizophrenia and Bipolarity type I

This study is looking at further assess ERG components obtained with different ERG devices, to be considered in a prediction model for each diagnosis for people with Schizophrenia or Bipolarity I. Participants are followed over time so researchers can learn from clinical and follow-up information.

In Australia
Bipolarity, SchizophreniaDeviceA study involving a tool, app, wearable, test, or medical device.From 18 Years to 50 Years
Countries
United States, Australia, Canada
Sponsor
diaMentis Inc.
Condition
Bipolarity, Schizophrenia
Data coverage

Public registry coverage is progressing

HopeStage gathers information about mental health clinical trials from the public registries we currently index. We are progressively improving registry coverage, but this does not mean that every study in the world is already included.